The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Cravath, Swaine & Moore LLP

WORLDWIDE PLAZA, 825 EIGHTH AVENUE, 10019-7475, USA
Tel:
Work +1 212 474 1000
Fax:
Fax +1 212 474 3700
Email:
Web:
www.cravath.com
London, NEW YORK

David Greenwald

Tel:
Work (212) 474-1922
Email:
Web:
www.cravath.com/dgreenwald/
Cravath, Swaine & Moore LLP

Work Department

Litigation.

Position

David Greenwald is a partner in Cravath’s Litigation Department. His areas of focus are patent litigation (particularly concerning chemical, pharmaceutical, and biotechnological patents) and white collar criminal defense.

Education

 


United States: Dispute resolution

Corporate investigations and white-collar criminal defense

Within: Corporate investigations and white-collar criminal defense

The 'extremely service-minded' team at Cravath, Swaine & Moore LLP has 'great expertise in relation to FCPA investigations, particularly related to the SEC'. David Stuart (who is 'always calm in stressful situations') and Daniel Slifkin are representing Insys Therapeutics in an SEC investigation into the company's financial restatement and disclosures, sales and marketing practices and compliance program. In another key matter, David Greenwald is representing two Swiss banks in connection with DOJ and IRS investigations into their provision of banking services to US taxpayers. 'Always firm and to the point', Rachel Skaistis is recommended alongside Benjamin Gruenstein and 'first-tier lawyer' John Buretta, who commands 'great respect from prosecutors'.

[back to top]

United States: Intellectual property

Patents: litigation (full coverage)

Within: Patents: litigation (full coverage)

Cravath, Swaine & Moore LLP in New York has particular strengths in the pharmaceuticals and telecoms sectors. On the pharmaceuticals side, Keith Hummel and David Greenwald defended Amgen in pioneering BPCIA litigation brought by AbbVie in 2016, alleging infringement of ten AbbVie patents by Amgen's Amjevita, a biosimilar to blockbuster drug Humira. On the telecoms side, the group represents Qualcomm in a series of suits regarding modem chips, including several cases against Apple and a case against the Federal Trade Commission concerning an alleged breach of Section 5 of the Federal Trade Act. A major technology highlight was the successful representation of Alarm.com in a Federal Circuit case following IPRs against Vivint, which had filed for patent infringement of home security technology patents. Other notable instructions came from DRI Capital, Juno Therapeutics and OrbusNeich. Richard Stark, David Kappos, David Greenwald and chairman Evan Chesler are other names to note. Vanessa Lavely made partner, and former US district judge Katherine Forrest joined the team.

Cravath, Swaine & Moore LLP in New York has particular strengths in the pharmaceuticals and telecoms sectors. On the pharmaceuticals side, Keith Hummel and David Greenwald defended Amgen in pioneering BPCIA litigation brought by AbbVie in 2016, alleging infringement of ten AbbVie patents by Amgen's Amjevita, a biosimilar to blockbuster drug Humira. On the telecoms side, the group represents Qualcomm in a series of suits regarding modem chips, including several cases against Apple and a case against the Federal Trade Commission concerning an alleged breach of Section 5 of the Federal Trade Act. A major technology highlight was the successful representation of Alarm.com in a Federal Circuit case following IPRs against Vivint, which had filed for patent infringement of home security technology patents. Other notable instructions came from DRI Capital, Juno Therapeutics and OrbusNeich. Richard Stark, David Kappos, David Greenwald and chairman Evan Chesler are other names to note. Vanessa Lavely made partner, and former US district judge Katherine Forrest joined the team.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Communiqu√© on Equity Crowdfunding Is Officially Published

    By way of background, in January 2019, the Capital Markets Board (‚Äú CMB ‚ÄĚ) had issued an announcement on its website on the Draft Communiqu√© on Equity Crowdfunding [1] . The CMB has now officially published the Communiqu√© on Crowdfunding No. III-35/A (‚Äú Communiqu√© ‚ÄĚ), on October 3, 2019. The Communiqu√© entered into force as of October 3, 2019.
  • Beneficial Ownership Concept new interpretation from the Russian federal tax service

    The recent interpretative letter issued by the Russian Federal Tax Services (‚ÄúFTS‚ÄĚ) on 08th August 2019, has provided further guidance as to the application of the Beneficial Ownership Concept, further to the letter initially provided on the 12th of April 2018 which adopted a strict approach of the concept.¬†
  • Cyprus and Netherlands Double Tax Treaty Update

    Cyprus has concluded the negotiations for the avoidance of double taxation with the Netherlands. The double tax treaty was agreed at technocratic level in Hague. It is expected to be signed by the end of 2019 or early in 2020.
  • Vacancy - Senior Corporate Lawyer

    The Senior Corporate Lawyer, who will be reporting to Partners, will be working with both the firm’s legal team as well as the financial services team. The successful candidate will be requested to show initiative, take on certain responsibilities within the firm, work in a multinational environment and will immediately be given the opportunity to further advance their career within the law firm.
  • CJEU RULED ON THE APPLICATION OF THE BENEFICIAL OWNERSHIP CONCEPT

    The judgment of the Court of Justice of the European Union (CJEU) on February 26, 2019, in the ‚ÄúDanish Beneficial Ownership Cases‚ÄĚ, can be perceived as a landmark on the interpretation of the Beneficial Ownership concept under the Interest and Royalties Directive (IRD) and the Parent-Subsidiary Directive (PSD).
  • Court of Justice rules on source of income for Derivative Residence applications

    On 2 October 2019, the Court of Justice delivered its judgment in Bajratari v Secretary of State for the Home Department (Directive 2004/38/EC) Case C-93/18 which concerns Chen applications and the source of funds for self-sufficiency. 
  • End of the ‚Äėcentre of life test‚Äô in Surinder Singh cases?

    In the recent case of¬† ZA (Reg 9. EEA Regs; abuse of rights) Afghanistan ¬† [2019] UKUT 281 (IAC ), the Upper Tribunal found that there is no basis in EU law for the centre of life test, as set out in Regulation 9(3)(a) of the Immigration (European Economic Area) Regulations 2016 (the ‚ÄúRegulations‚ÄĚ). It further found that it is not to be applied when Judges assess ¬†Surinder Singh ¬†cases that appear before them.
  • ITALIAN RULES ON JOINT VENTURES IN PUBLIC PROCUREMENT AND CONCESSIONS

    Italian rules on jointventures concerning public procurement and concession contracts are set out inlight of the European legal framework provided for in Directive 2014/23/EU and 2014/24/EU of the European Parliament and of the Council. The European rules aim to ensurethe best use of public money so that EU citizens benefit from strategicinvestments and services at fair prices. In this context, public procurementand concessions represent key instruments that need to be regulated and standardisedin order to ensure free movement of goods, freedom of establishment and freedomto provide services.
  • Terms of employment as a sole representative

    In this article we examine the working arrangements of sole representatives, looking at the terms and conditions of employment that the Home Office will expect a sole representative to have in order to qualify as a representative of an overseas business.  
  • Can Sole Representatives Be Shareholders?

    The Immigration Rules require that an applicant for a¬† sole representative visa ¬†is not ‚Äúa¬† majority shareholder in the overseas business‚ÄĚ.